What the TRAVERSE Trial Reveals About Testosterone, Desire, and Lasting Vitality
For many men, the earliest sign that something has shifted is not fatigue or a change in body composition. It is desire. The quiet tapering of sexual interest, the less frequent impulse, the sense that intimacy requires more intention than it once did. These changes are common, yet they are rarely discussed with the precision they deserve.
The TRAVERSE trial—the largest randomized, placebo-controlled study of testosterone therapy conducted to date—offers one of the clearest pictures we have of what carefully monitored testosterone replacement can do for sexual desire and activity, and under what conditions the benefits are most likely to appear.
A Trial Designed for Clarity
TRAVERSE enrolled more than 5,200 men between the ages of 45 and 80 who had documented low testosterone (two morning levels below 300 ng/dL), symptoms consistent with hypogonadism, and either existing cardiovascular disease or elevated cardiovascular risk. Participants received either 1.62% testosterone gel or a matching placebo, with doses adjusted to keep levels in a physiologic range.
The primary aim was cardiovascular safety. On that measure, testosterone therapy proved non-inferior to placebo for major adverse cardiovascular events over an average of roughly 33 months of follow-up. Prostate cancer diagnoses were also comparable between the groups. These findings have reshaped the conversation around testosterone therapy for appropriately selected men.
The Findings That Matter Most for Desire
A dedicated sexual function analysis nested within TRAVERSE focused on the 1,161 participants who entered the trial with low libido. Here the results were both specific and durable.
Men receiving testosterone experienced greater improvements in sexual activity than those receiving placebo. The difference was approximately half an additional sexual act per day at both six and twelve months, and the benefit was maintained through 24 months of treatment. Sexual desire itself also improved, as did broader hypogonadal symptoms.
Notably, the trial did not show a significant improvement in erectile function compared with placebo. This distinction is useful. Testosterone therapy appears most reliable for restoring interest and the frequency of sexual activity in men who begin with low desire, rather than as a primary treatment for erectile difficulties driven by vascular or other factors.
In clinical terms, the effect is modest in magnitude yet consistent and sustained. For men who have felt the gradual quieting of desire, that consistency can be meaningful: a return of interest that does not fade after the first few months.
Why Context Matters
These sexual benefits occurred in men who met clear diagnostic criteria—confirmed low testosterone plus compatible symptoms—and who were monitored throughout treatment. The same trial, and related real-world analyses, underscore that results are not automatically transferable to men without documented hypogonadism or to unmonitored use.
Other signals from TRAVERSE included modest improvements in mood and higher rates of certain adverse events (including atrial fibrillation and pulmonary embolism) in the testosterone group. Individual risk assessment, ongoing laboratory monitoring, and attention to fertility goals remain essential. Testosterone therapy is not a universal enhancer; it is a targeted intervention whose value depends on accurate diagnosis and careful oversight.
The Case for a Comprehensive Starting Point
The practical implication of TRAVERSE is straightforward. When low desire is accompanied by confirmed low testosterone and other compatible symptoms, properly managed testosterone therapy can restore a measurable and sustained degree of sexual interest and activity. Determining whether that description applies to any given man requires more than a single number or a list of symptoms.
A comprehensive laboratory panel, interpreted in the context of a full clinical history, provides the necessary foundation. It clarifies whether testosterone is low, whether related hormones or metabolic factors are contributing, and what a responsible, individualized plan would look like. At Umber Health, every path begins there: a private consultation followed by detailed labs, so that any recommendation rests on data rather than assumption.
If low desire or a broader sense of diminished vitality has become noticeable, the most useful next step is clarity. Book a comprehensive lab panel to establish your baseline and begin a precise conversation about whether testosterone optimization is appropriate for you.
A note on this content
This article is for educational purposes only and is not medical advice, diagnosis, or a recommendation for treatment. Individual results vary. Any decision about testosterone therapy should be made with a qualified clinician after appropriate evaluation, including laboratory testing and a review of your medical history.
Related Services
Testosterone Therapy
Restore energy, strength, libido, and mental clarity with clinically guided TRT.
Sexual Wellness
Confidential telehealth for sexual wellness concerns.
Longevity Medicine
Turn long-term goals into priorities today, starting with your history, function, and habits.
